5-methoxy-dimethyltryptamine (5-meo-DMT)

Clinical trials for 5-methoxy-dimethyltryptamine (5-meo-DMT) explained in plain language.

Never miss a new study

Get alerted when new 5-methoxy-dimethyltryptamine (5-meo-DMT) trials appear

Sign up with your email to follow new studies for 5-methoxy-dimethyltryptamine (5-meo-DMT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Psychedelic 5-MeO-DMT infused in healthy brains: first safety data coming

Knowledge-focused Recruiting now

This early-stage trial is testing how safe and tolerable intravenous 5-MeO-DMT is in 40 healthy adults aged 25-65. Participants receive either a low dose of the psychedelic or a placebo, and researchers monitor their subjective experiences, vital signs, and side effects. The goal…

Matched conditions: 5-METHOXY-DIMETHYLTRYPTAMINE (5-MEO-DMT)

Phase 1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused

Last updated Jun 27, 2026 09:10 UTC

5-methoxy-dimethyltryptamine (5-meo-DMT)

Get alerted when new 5-methoxy-dimethyltryptamine (5-meo-DMT) trials appear

Psychedelic 5-MeO-DMT infused in healthy brains: first safety data coming